{"id":920896,"date":"2025-12-18T09:23:24","date_gmt":"2025-12-18T14:23:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/"},"modified":"2025-12-18T09:23:24","modified_gmt":"2025-12-18T14:23:24","slug":"simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/","title":{"rendered":"Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development<\/b><\/p>\n<p class=\"bwalignc\"><b><i>Driving Growth with Integrated Software, Services, and AI-Enabled Ecosystem<\/i><\/b><\/p>\n<p>RESEARCH TRIANGLE PARK, N.C.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nSimulations Plus, Inc. (Nasdaq: SLP) (\u201cSimulations Plus\u201d or the \u201cCompany\u201d), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that it will host a virtual Investor Day on Wednesday, January 21, 2026.\n<\/p>\n<p>\nThe event will offer investors and analysts an in-depth look at the Company\u2019s long-term strategy, product roadmap, and financial outlook, as well as a Q&amp;A session with the executive leadership team.\n<\/p>\n<p>\n\u201cBiopharma companies are rethinking how they develop medicines\u2014prioritizing greater predictability, transparency, and scientific rigor at every step. Simulations Plus sits at the intersection of these needs,\u201d said Shawn O\u2019Connor, Chief Executive Officer of Simulations Plus. \u201cWe are committed to helping our clients navigate this complexity with clarity and confidence. During Investor Day, we will demonstrate how our unified strategy positions us to support the next era of innovation in drug development.\u201d\n<\/p>\n<p>\nAttendees will gain insight into Simulations Plus\u2019 vision for an integrated, AI-enabled modeling ecosystem spanning discovery, development, clinical operations, and commercialization. The agenda will include updates on:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nThe industry environment and the accelerating adoption of model-informed drug development (MIDD)\n<\/li>\n<li>\nThe Company\u2019s unified product and technology strategy\n<\/li>\n<li>\nAdvances in scientific services supporting client workflows across the drug lifecycle\n<\/li>\n<li>\nFinancial priorities and outlook\n<\/li>\n<\/ul>\n<p>\nThe event will be webcast live, and a replay will be posted following the event.\n<\/p>\n<p><b>Event Details<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><b>Date:<\/b> Wednesday, January 21, 2026\n<\/li>\n<li><b>Time:<\/b> 1:00 PM ET \u2013 2:30 PM ET\n<\/li>\n<li><b>Location:<\/b> Virtual\n<\/li>\n<li><b>Webcast Registration:<\/b><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fviavid.webcasts.com%2Fstarthere.jsp%3Fei%3D1746953%26tp_key%3D9c26ec8281&amp;esheet=54378396&amp;newsitemid=20251218867761&amp;lan=en-US&amp;anchor=Here&amp;index=1&amp;md5=4dfc5399965364b28e65167c37ac8cd3\">Here<\/a><\/li>\n<\/ul>\n<p><b>About Simulations Plus, Inc.<\/b><\/p>\n<p>\nSimulations Plus is a global leader in model-informed and AI-accelerated drug development. We create value for our clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through innovative science-based software and consulting solutions. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam12.safelinks.protection.outlook.com%2F%3Furl%3Dhttp%253A%252F%252Fwww.simulations-plus.com%252F%26data%3D05%257C02%257Cchristina.hendrickson%2540simulations-plus.com%257Ce00a5e418fc14363254b08de337406c4%257Ca6fe9a739e054efcb9b3f4cc5eab196c%257C0%257C0%257C639004771726597036%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3DVl%252BNsGSLmZtDcsrlp0M1V9NI3JD3jT5%252BD3bn1M3Ffn8%253D%26reserved%3D0&amp;esheet=54378396&amp;newsitemid=20251218867761&amp;lan=en-US&amp;anchor=www.simulations-plus.com&amp;index=2&amp;md5=61e5874352f192e50c86cc72877232a0\">www.simulations-plus.com<\/a>.\n<\/p>\n<p><b>Environmental, Social, and Governance<\/b><\/p>\n<p>\nWe focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.simulations-plus.com%2Finvestorscorporate-profile%2Fenvironmental-social-and-governance-esg%2F&amp;esheet=54378396&amp;newsitemid=20251218867761&amp;lan=en-US&amp;anchor=visit+our+website&amp;index=3&amp;md5=49a470cbcfc55e3944941b297a25c648\">visit our website<\/a>.\n<\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p>\nExcept for historical information, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties. Words like \u201cbelieve,\u201d \u201cwill\u201d, \u201ccan\u201d, \u201cbelieve\u201d, \u201cexpect,\u201d \u201canticipate\u201d and similar expressions (or the negative of such terms, as well as other words or expressions referencing future events, conditions or circumstances) mean that these are our best estimates as of this writing, but there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. These forward-looking statements are based on current assumptions and expectations that involve risks and uncertainties that could cause the actual results to differ materially from those expressed or implied. Factors that could cause or contribute to such differences include, but are not limited to: effectiveness of our new internal operational structure, our ability to maintain our competitive advantages and commercialize AI and cloud-enabled solutions, evolving regulatory and data privacy standards governing AI technologies, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, market conditions, macroeconomic factors, and a sustainable market. Further information on our risk factors is contained in our quarterly, annual and current reports and filed with the U.S. Securities and Exchange Commission.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251218867761r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20251218867761\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20251218867761\/en\/<\/a><\/span><\/p>\n<p><b>Investor Relations Contact<\/b>:<br \/>\n<br \/>Lisa Fortuna<br \/>\n<br \/>Financial Profiles<br \/>\n<br \/>310-622-8251<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:slp@finprofiles.com\">slp@finprofiles.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> North Carolina United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Research Technology Clinical Trials Health Technology Software Biotechnology Pharmaceutical Health Science Artificial Intelligence<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251218867761\/en\/2672189\/3\/SLP-Logo-Stacked.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development Driving Growth with Integrated Software, Services, and AI-Enabled Ecosystem RESEARCH TRIANGLE PARK, N.C.&#8211;(BUSINESS WIRE)&#8211; Simulations Plus, Inc. (Nasdaq: SLP) (\u201cSimulations Plus\u201d or the \u201cCompany\u201d), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that it will host a virtual Investor Day on Wednesday, January 21, 2026. The event will offer investors and analysts an in-depth look at the Company\u2019s long-term strategy, product roadmap, and financial outlook, as well as a Q&amp;A session with the executive leadership team. \u201cBiopharma companies are rethinking how they develop medicines\u2014prioritizing greater predictability, transparency, and scientific rigor at every step. Simulations Plus sits &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-920896","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development Driving Growth with Integrated Software, Services, and AI-Enabled Ecosystem RESEARCH TRIANGLE PARK, N.C.&#8211;(BUSINESS WIRE)&#8211; Simulations Plus, Inc. (Nasdaq: SLP) (\u201cSimulations Plus\u201d or the \u201cCompany\u201d), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that it will host a virtual Investor Day on Wednesday, January 21, 2026. The event will offer investors and analysts an in-depth look at the Company\u2019s long-term strategy, product roadmap, and financial outlook, as well as a Q&amp;A session with the executive leadership team. \u201cBiopharma companies are rethinking how they develop medicines\u2014prioritizing greater predictability, transparency, and scientific rigor at every step. Simulations Plus sits &hellip; Continue reading &quot;Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-18T14:23:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251218867761r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development\",\"datePublished\":\"2025-12-18T14:23:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\\\/\"},\"wordCount\":652,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251218867761r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\\\/\",\"name\":\"Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251218867761r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-12-18T14:23:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251218867761r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251218867761r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/","og_locale":"en_US","og_type":"article","og_title":"Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development - Market Newsdesk","og_description":"Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development Driving Growth with Integrated Software, Services, and AI-Enabled Ecosystem RESEARCH TRIANGLE PARK, N.C.&#8211;(BUSINESS WIRE)&#8211; Simulations Plus, Inc. (Nasdaq: SLP) (\u201cSimulations Plus\u201d or the \u201cCompany\u201d), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that it will host a virtual Investor Day on Wednesday, January 21, 2026. The event will offer investors and analysts an in-depth look at the Company\u2019s long-term strategy, product roadmap, and financial outlook, as well as a Q&amp;A session with the executive leadership team. \u201cBiopharma companies are rethinking how they develop medicines\u2014prioritizing greater predictability, transparency, and scientific rigor at every step. Simulations Plus sits &hellip; Continue reading \"Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-18T14:23:24+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251218867761r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development","datePublished":"2025-12-18T14:23:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/"},"wordCount":652,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251218867761r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/","name":"Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251218867761r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-12-18T14:23:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251218867761r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251218867761r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-to-host-virtual-investor-day-highlighting-strategy-for-the-next-era-of-model-informed-drug-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/920896","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=920896"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/920896\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=920896"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=920896"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=920896"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}